Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodies

Cell Host and Microbe

Volumn 13, Issue 4, 2013, Pages 417-428

  Chow, Siu Kei ^a   Smith, Cameron ^a   Maccarthy, Thomas ^a   Pohl, Mary Ann ^a   Bergman, Aviv ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN NEUTRALIZING ANTIBODY; EPITOPE; FC RECEPTOR; IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACILLUS ANTHRACIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STOICHIOMETRY;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS);

EID: 84876393994     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2013.03.001     Document Type: Article

References (61)

1. N. Abboud, M. De Jesus, A. Nakouzi, R.J. Cordero, M. Pujato, A. Fiser, J. Rivera, and A. Casadevall Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies J. Biol. Chem. 284 2009 25077 25086
2. N. Abboud, S.K. Chow, C. Saylor, A. Janda, J.V. Ravetch, M.D. Scharff, and A. Casadevall A requirement for FcγR in antibody-mediated bacterial toxin neutralization J. Exp. Med. 207 2010 2395 2405
3. R. Ablowitz The theory of emergence Phil. Sci. 6 1939 1 16
4. A. Aderem, and D.M. Underhill Mechanisms of phagocytosis in macrophages Annu. Rev. Immunol. 17 1999 593 623
5. P. Anderson, M. Caligiuri, C. O'Brien, T. Manley, J. Ritz, and S.F. Schlossman Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells Proc. Natl. Acad. Sci. USA 87 1990 2274 2278
6. U.S. Bhalla, and R. Iyengar Emergent properties of networks of biological signaling pathways Science 283 1999 381 387
7. F. Brossier, M. Lévy, A. Landier, P. Lafaye, and M. Mock Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies Infect. Immun. 72 2004 6313 6317
8. A. Casadevall, F.C. Fang, and L.A. Pirofski Microbial virulence as an emergent property: consequences and opportunities PLoS Pathog. 7 2011 e1002136 10.1371/journal.ppat.1002136
9. Z. Chen, M. Moayeri, D. Crown, S. Emerson, I. Gorshkova, P. Schuck, S.H. Leppla, and R.H. Purcell Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody Infect. Immun. 77 2009 3902 3908
10. L.W. Cheng, L.H. Stanker, T.D. Henderson 2nd, J. Lou, and J.D. Marks Antibody protection against botulinum neurotoxin intoxication in mice Infect. Immun. 77 2009 4305 4313
11. S.K. Chow, and A. Casadevall Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis Vaccine 29 2011 1891 1898
12. S.K. Chow, and A. Casadevall Monoclonal antibodies and toxins - a perspective on function and isotype Toxins (Basel) 4 2012 430 454
13. L.A. Chylek, B. Hu, M.L. Blinov, T. Emonet, J.R. Faeder, B. Goldstein, R.N. Gutenkunst, J.M. Haugh, T. Lipniacki, and R.G. Posner Guidelines for visualizing and annotating rule-based models Mol. Biosyst. 7 2011 2779 2795
14. R.J. Colonno, P.L. Callahan, D.M. Leippe, R.R. Rueckert, and J.E. Tomassini Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments J. Virol. 63 1989 36 42
15. R.J. Cordero, S. Frases, A.J. Guimaräes, J. Rivera, and A. Casadevall Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity Mol. Microbiol. 79 2011 1101 1117
16. P.A. Corning The re-emergence of "emergence": a venerable concept in search for a theory Complexity 7 2002 18 30
17. M. De Jesus, S.K. Chow, R.J. Cordero, S. Frases, and A. Casadevall Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable Eukaryot. Cell 9 2010 1018 1028
18. W. Dejnirattisai, A. Jumnainsong, N. Onsirisakul, P. Fitton, S. Vasanawathana, W. Limpitikul, C. Puttikhunt, C. Edwards, T. Duangchinda, and S. Supasa Cross-reacting antibodies enhance dengue virus infection in humans Science 328 2010 745 748
19. S.J. Demarest, M. Hariharan, M. Elia, J. Salbato, P. Jin, C. Bird, J.M. Short, B.E. Kimmel, M. Dudley, G. Woodnutt, and G. Hansen Neutralization of Clostridium difficile toxin A using antibody combinations MAbs 2 2010 190 198
20. S.F. de StGroth, and D. Scheidegger Production of monoclonal antibodies: strategy and tactics J. Immunol. Methods 35 1980 1 21
21. J.R. Faeder, M.L. Blinov, and W.S. Hlavacek Rule-based modeling of biochemical systems with BioNetGen Methods Mol. Biol. 500 2009 113 167
22. J.W. Froude 2nd, P. Thullier, and T. Pelat Antibodies against anthrax: mechanisms of action and clinical applications Toxins (Basel) 3 2011 1433 1452
23. D.T. Gillespie Exact stochastic simulation of coupled chemical reactions J. Phys. Chem. 81 1977 2340 2361
24. L.J. Gleser Exact power of goodness-of-fit tests of Kolmogorov type for discontinuous distributions J. Am. Stat. Assoc. 80 1985 954 958
25. E.A. Henchal, L.S. Henchal, and J.J. Schlesinger Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus J. Gen. Virol. 69 1988 2101 2107
26. S. Kanjilal, R. Citorik, R.C. LaRocque, M.F. Ramoni, and S.B. Calderwood A systems biology approach to modeling vibrio cholerae gene expression under virulence-inducing conditions J. Bacteriol. 192 2010 4300 4310
27. A.F. Kintzer, K.L. Thoren, H.J. Sterling, K.C. Dong, G.K. Feld, I.I. Tang, T.T. Zhang, E.R. Williams, J.M. Berger, and B.A. Krantz The protective antigen component of anthrax toxin forms functional octameric complexes J. Mol. Biol. 392 2009 614 629
28. G. Köhler, and C. Milstein Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256 1975 495 497
29. S.F. Little, S.H. Leppla, and E. Cora Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin Infect. Immun. 56 1988 1807 1813
30. S.F. Little, W.M. Webster, and D.E. Fisher Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo FEMS Immunol. Med. Microbiol. 62 2011 11 22
31. T. Logtenberg Antibody cocktails: next-generation biopharmaceuticals with improved potency Trends Biotechnol. 25 2007 390 394
32. I. Lowy, D.C. Molrine, B.A. Leav, B.M. Blair, R. Baxter, D.N. Gerding, G. Nichol, W.D. Thomas Jr., M. Leney, and S. Sloan Treatment with monoclonal antibodies against Clostridium difficile toxins N. Engl. J. Med. 362 2010 197 205
33. M. Maddaloni, C. Cooke, R. Wilkinson, A.V. Stout, L. Eng, and S.H. Pincus Immunological characteristics associated with the protective efficacy of antibodies to ricin J. Immunol. 172 2004 6221 6228
34. I. Mellman, and H. Plutner Internalization and degradation of macrophage Fc receptors bound to polyvalent immune complexes J. Cell Biol. 98 1984 1170 1177
35. T.S. Migone, G.M. Subramanian, J. Zhong, L.M. Healey, A. Corey, M. Devalaraja, L. Lo, S. Ullrich, J. Zimmerman, and A. Chen Raxibacumab for the treatment of inhalational anthrax N. Engl. J. Med. 361 2009 135 144
36. M. Moayeri, and S.H. Leppla Cellular and systemic effects of anthrax lethal toxin and edema toxin Mol. Aspects Med. 30 2009 439 455
37. J. Mogridge, K. Cunningham, D.B. Lacy, M. Mourez, and R.J. Collier The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen Proc. Natl. Acad. Sci. USA 99 2002 7045 7048
38. N. Mohamed, J. Li, C.S. Ferreira, S.F. Little, A.M. Friedlander, G.L. Spitalny, and L.S. Casey Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages Infect. Immun. 72 2004 3276 3283
39. S.S. Molloy, P.A. Bresnahan, S.H. Leppla, K.R. Klimpel, and G. Thomas Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen J. Biol. Chem. 267 1992 16396 16402
40. H. Mouquet, J.F. Scheid, M.J. Zoller, M. Krogsgaard, R.G. Ott, S. Shukair, M.N. Artyomov, J. Pietzsch, M. Connors, and F. Pereyra Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation Nature 467 2010 591 595
41. J. Mukherjee, M.D. Scharff, and A. Casadevall Protective murine monoclonal antibodies to Cryptococcus neoformans Infect. Immun. 60 1992 4534 4541
42. M.M. Ngundi, B.D. Meade, S.F. Little, C.P. Quinn, C.R. Corbett, R.A. Brady, and D.L. Burns Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action Clin. Vaccine Immunol. 19 2012 731 739
43. G. Nussbaum, R. Yuan, A. Casadevall, and M.D. Scharff Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans J. Exp. Med. 183 1996 1905 1909
44. J.S. Peiris, and J.S. Porterfield Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines Nature 282 1979 509 511
45. K. Pethe, S. Alonso, F. Biet, G. Delogu, M.J. Brennan, C. Locht, and F.D. Menozzi The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination Nature 412 2001 190 194
46. C. Petosa, R.J. Collier, K.R. Klimpel, S.H. Leppla, and R.C. Liddington Crystal structure of the anthrax toxin protective antigen Nature 385 1997 833 838
47. M. Potter, and R. Lieberman Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline J. Exp. Med. 132 1970 737 751
48. T.D. Querec, R.S. Akondy, E.K. Lee, W. Cao, H.I. Nakaya, D. Teuwen, A. Pirani, K. Gernert, J. Deng, and B. Marzolf Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans Nat. Immunol. 10 2009 116 125
49. M. Radjainia, J.K. Hyun, C.E. Leysath, S.H. Leppla, and A.K. Mitra Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex Proc. Natl. Acad. Sci. USA 107 2010 14070 14074
50. J. Rivera, A. Nakouzi, N. Abboud, E. Revskaya, D. Goldman, R.J. Collier, E. Dadachova, and A. Casadevall A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1 Infect. Immun. 74 2006 4149 4156
51. J.G. Salfeld Isotype selection in antibody engineering Nat. Biotechnol. 25 2007 1369 1372
52. C. Saylor, E. Dadachova, and A. Casadevall Monoclonal antibody-based therapies for microbial diseases Vaccine 27 Suppl 6 2009 G38 G46
53. J.F. Scheid, H. Mouquet, B. Ueberheide, R. Diskin, F. Klein, T.Y. Oliveira, J. Pietzsch, D. Fenyo, A. Abadir, and K. Velinzon Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding Science 333 2011 1633 1637
54. C.P. Taborda, J. Rivera, O. Zaragoza, and A. Casadevall More is not necessarily better: prozone-like effects in passive immunization with IgG J. Immunol. 170 2003 3621 3630
55. A. Takada, and Y. Kawaoka Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications Rev. Med. Virol. 13 2003 387 398
56. T. Takai, M. Li, D. Sylvestre, R. Clynes, and J.V. Ravetch FcR gamma chain deletion results in pleiotrophic effector cell defects Cell 76 1994 519 529
57. A. Takeda, C.U. Tuazon, and F.A. Ennis Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry Science 242 1988 580 583
58. A.A. Thomas, P. Brioen, and A. Boeyé A monoclonal antibody that neutralizes poliovirus by cross-linking virions J. Virol. 54 1985 7 13
59. A.K. Varshney, X. Wang, E. Cook, K. Dutta, M.D. Scharff, M.J. Goger, and B.C. Fries Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock J. Biol. Chem. 286 2011 9737 9747
60. S.L. Welkos, T.J. Keener, and P.H. Gibbs Differences in susceptibility of inbred mice to Bacillus anthracis Infect. Immun. 51 1986 795 800
61. L. Winterroth, J. Rivera, A.S. Nakouzi, E. Dadachova, and A. Casadevall Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax Infect. Immun. 78 2010 2890 2898